Neoplasm
RecruitingStudy of Zenocutuzumab for Patients with Solid Tumors with NRG1 Fusion
Study of Zenocutuzumab for Patients with Solid Tumors with NRG1 Fusion
- Disease:Neoplasm
- Substances:–
Austria- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
Study of Zenocutuzumab for Patients with Solid Tumors with NRG1 Fusion
AustriaStudy on Acalabrutinib and Obinutuzumab vs. Venetoclax and Obinutuzumab for Newly Diagnosed Chronic Lymphocytic Leukemia Patients
PolandStudy on Denosumab for Treating Fibrous Dysplasia/McCune-Albright Syndrome in Adults
The NetherlandsStudy on the Safety and Effectiveness of Sodium Zirconium Cyclosilicate for Children with High Potassium Levels
GermanyStudy on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients
AustriaSafety Study of (+)-α-Dihydrotetrabenazine for Patients with Moderate to Severe Tardive Dyskinesia
CzechiaStudy on the Effectiveness of Clopidogrel, Prasugrel, and Ticagrelor in Patients with Coronary Acute Syndrome Using VerifyNow Device
SpainStudy on the Safety and Tolerability of STK-002 for Patients with Autosomal Dominant Optic Atrophy
AustriaStudy on Nitrous Oxide and Oxygen for Treating Depression in Nursing Home Residents with Neurocognitive Disorders
FranceStudy on the Effects of Rilvegostomig and Drug Combination for Patients with Advanced Gastric or Gastroesophageal Junction Cancer
SpainStudy on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients
AustriaStudy on Low-Dose Aldesleukin for Patients with Pemphigus, Mucous Membrane Pemphigoid, Polymyositis, Dermatomyositis, and Primary Sclerosing Cholangitis
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.